Sort by
Refine Your Search
-
Summary Applicants are invited to undertake a 3 year PhD program in partnership with a global leader in blood- and cell-based therapies (Terumo Blood and Cell Technologies Ltd). This opportunity
-
for metabolic disorders such as diabetes and obesity. However, their efficacy and safety in humans remains unexplored. This PhD programme will seek to take the first critical step towards clinical translation
-
the sustainable growth of the regional life sciences economy. Important Information: Applications for more than one PhD studentship are welcome, however if you apply for more than one PhD project within Biomedical
-
on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award. *Part time PhD
-
applicants from diverse academic and professional backgrounds, including (but not limited to): Film, Television, and Media Studies Artificial Intelligence and Computer Science Creative Arts and Practice-based
-
. Important Information: Applications for more than one PhD studentship are welcome, however if you apply for more than one PhD project within Biomedical Sciences, your first application on the system will be
-
for more than one PhD project within Biomedical Sciences, your first application on the system will be deemed your first-choice preference and further applications will be ordered based on the sequential time of
-
manufacturing engineering and biosensing enabling the fabrication of highly sensitive, room-temperature quantum sensors using scalable, low-energy processes. Essential criteria Applicants should hold, or expect
-
there is less in the way of support for changes in research laboratories. The Microbiology Group in the School of Biomedical Sciences is the ideal test-bed to investigate procedures and approaches. It is a
-
Pharmacist-Led Medicines Optimisation in Metabolic care: a Cross-System Implementation Science Study
Apply and key information This project is funded by: Department for the Economy (DfE) Summary This PhD programme will develop and evaluate AI-assisted, pharmacist-led clinical decision-support